CLABF.US Core One Labs Inc

Healthcare Biotechnology USA Stocks
0.0000 USD
Close of Nov 14, 2026
Market cap
USD 470.00
P/E
-
P/B
0.21x
ROE
-58.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2023.

Is CLABF.US undervalued?

Graham number

The Graham number of Core One Labs Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Core One Labs Inc fundamental analysis

No fundamental analysis for Core One Labs Inc yet.

Core One Labs Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Core One Labs Inc

Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was…

Full company profile